TREACE MEDICAL CONCEPTS, INC. (TMCI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US89455T1097
TREACE MEDICAL CONCEPTS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 212.69 m USD |
| Gross profit | 169.75 m USD |
| Operating income | -54.15 m USD |
| EBIT | -53.68 m USD |
| Net income | -59.00 m USD |
| Diluted EPS – continuing operations | -0.93 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TREACE MEDICAL CONCEPTS, INC.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
More stocks
- Zhangjiagang Zhonghuan Hailu High-End Equipment Co. Ltd. (301040.SZ)
- Hyundai Motor Securities Co. Ltd. (001500.KS)
- XiAn Dagang Road Machinery Co (300103.SZ)
- Hota Industrial Mfg. Co Ltd (1536.TW)
- Zhejiang Meilun Elevator Co Ltd (603321.SS)
- GALECTIN THERAPEUTICS INC (GALT)
- Hunan Investment Group Co Ltd (000548.SZ)
- Locaweb Serviços de Internet S.A. (LWSA3.SA)
- Guangdong Anjubao Digital Tech (300155.SZ)
- CoastalSouth Bancshares, Inc. (COSO)
- J.Jill, Inc. (JILL)
- Deutsche Balaton (BBHK.HM)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.